103 related articles for article (PubMed ID: 21173974)
1. Comparative analysis of nuclear estrogen receptor alpha and beta interactomes in breast cancer cells.
Nassa G; Tarallo R; Guzzi PH; Ferraro L; Cirillo F; Ravo M; Nola E; Baumann M; Nyman TA; Cannataro M; Ambrosino C; Weisz A
Mol Biosyst; 2011 Mar; 7(3):667-76. PubMed ID: 21173974
[TBL] [Abstract][Full Text] [Related]
2. A large set of estrogen receptor β-interacting proteins identified by tandem affinity purification in hormone-responsive human breast cancer cell nuclei.
Nassa G; Tarallo R; Ambrosino C; Bamundo A; Ferraro L; Paris O; Ravo M; Guzzi PH; Cannataro M; Baumann M; Nyman TA; Nola E; Weisz A
Proteomics; 2011 Jan; 11(1):159-65. PubMed ID: 21182203
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
4. Identification of proteins associated with ligand-activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS.
Tarallo R; Bamundo A; Nassa G; Nola E; Paris O; Ambrosino C; Facchiano A; Baumann M; Nyman TA; Weisz A
Proteomics; 2011 Jan; 11(1):172-9. PubMed ID: 21182205
[TBL] [Abstract][Full Text] [Related]
5. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
6. P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells.
Li HJ; Wang LY; Qu HN; Yu LH; Burnstock G; Ni X; Xu M; Ma B
Mol Cell Endocrinol; 2011 May; 338(1-2):28-37. PubMed ID: 21356271
[TBL] [Abstract][Full Text] [Related]
7. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.
Platet N; Cathiard AM; Gleizes M; Garcia M
Crit Rev Oncol Hematol; 2004 Jul; 51(1):55-67. PubMed ID: 15207254
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence.
Mc Ilroy M; Fleming FJ; Buggy Y; Hill AD; Young LS
Endocr Relat Cancer; 2006 Dec; 13(4):1135-45. PubMed ID: 17158759
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of estrogen receptor alpha serine 167 is predictive of response to endocrine therapy and increases postrelapse survival in metastatic breast cancer.
Yamashita H; Nishio M; Kobayashi S; Ando Y; Sugiura H; Zhang Z; Hamaguchi M; Mita K; Fujii Y; Iwase H
Breast Cancer Res; 2005; 7(5):R753-64. PubMed ID: 16168121
[TBL] [Abstract][Full Text] [Related]
10. Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.
den Hollander P; Rayala SK; Coverley D; Kumar R
Cancer Res; 2006 Nov; 66(22):11021-9. PubMed ID: 17108141
[TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients.
Cappelletti V; Celio L; Bajetta E; Allevi A; Longarini R; Miodini P; Villa R; Fabbri A; Mariani L; Giovanazzi R; Galante E; Greco M; Grazia Daidone M
Endocr Relat Cancer; 2004 Dec; 11(4):761-70. PubMed ID: 15613450
[TBL] [Abstract][Full Text] [Related]
12. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
[TBL] [Abstract][Full Text] [Related]
13. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
Macaluso M; Cinti C; Russo G; Russo A; Giordano A
Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
[TBL] [Abstract][Full Text] [Related]
14. Is oestrogen receptor-beta a predictor of endocrine therapy responsiveness in human breast cancer?
Murphy LC; Watson PH
Endocr Relat Cancer; 2006 Jun; 13(2):327-34. PubMed ID: 16728566
[TBL] [Abstract][Full Text] [Related]
15. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
[TBL] [Abstract][Full Text] [Related]
16. Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Carcinogenesis; 2005 Apr; 26(4):763-9. PubMed ID: 15637090
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of estrogen receptor alpha and beta and progesterone receptor expression and correlation with clinicopathologic factors and proliferative marker Ki-67 in breast cancers.
Rosa FE; Caldeira JR; Felipes J; Bertonha FB; Quevedo FC; Domingues MA; Moraes Neto FA; Rogatto SR
Hum Pathol; 2008 May; 39(5):720-30. PubMed ID: 18234277
[TBL] [Abstract][Full Text] [Related]
18. Identification of cytoplasmic proteins interacting with unliganded estrogen receptor α and β in human breast cancer cells.
Stellato C; Nassa G; Tarallo R; Giurato G; Ravo M; Rizzo F; Marchese G; Alexandrova E; Cordella A; Baumann M; Nyman TA; Weisz A; Ambrosino C
Proteomics; 2015 Jun; 15(11):1801-7. PubMed ID: 25604459
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
20. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
